19 Feb 2015 14:05
MD MEDICAL GROUP ANNOUNCES CHANGES
TO ITS BOARD OF DIRECTORS
19 February 2015, Moscow, Russia - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), Russia's leading provider of private women's and children's healthcare, today announces changes to its Board of Directors effective as of 19 February 2015.
The new members of the Board are:
1. Vitaly Ustimenko - executive director
2. Vladimir Mekler - non-executive director, member of Nomination Committee
3. Liubov Malyarevskaya - independent non-executive director, chairman of Audit Committee.
Dr Mark Kurtser, Chairman of the Board of Directors of MD Medical Group, said:
"It is a great pleasure to welcome Vitaly Ustimenko, Liubov Malyarevskaya and Vladimir Mekler to our Board. Mrs Malyarevskaya, a highly regarded expert in finance and accounting, will be chairing our Audit Committee. Mr Mekler who has substantial expertise in corporate law will be a member of Nomination Committee. All of them bring excellent experience and relevant skills, helping us to strengthen the work and efficiency of our Board still further."
The Board announces that Mr Apollon Athanasiades, Ms Elia Nicolaou, Mr Marios Tofaros, Mr Angelos Paphitis, Mr Andreas Petrides have confirmed their intention to resign from their posts of non-executive directors with effect from 18 February 2015.
The Board would like to express its sincere gratitude to Mr Apollon Athanasiades, Ms Elia Nicolaou, Mr Marios Tofaros, Mr Angelos Paphitis and Mr Andreas Petrides for their contributions to the Company during their tenure of service.
These Board changes are in line with the Company's intention to become a Russian tax resident, which became possible following changes to Russian tax legislation in effect as of 1 January 2015.
Biographies of the members of the Board of Directors and composition of its committees are available on the Company's website:
http://www.mcclinics.com/about/board/
There is no information required to be disclosed under Listing Rule 9.6.13R in respect of new members of the Board of Directors.
For further information please contact:
Investors | Media
|
Elena Romanova MD Medical Group Investments PlcTel: +7 495 331 4120e.romanova@mcclinics.ru | EMMoscowTom Blackwell / Sergii Pershyn Tel: +7 495 363 2849MDMG@em-comms.com
|
Consilium Strategic CommunicationsLondonEmma Thompson / Matthew Neal Tel: +44 20 7309 5700MDMG@em-comms.com |
About MD Medical Group
MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages 23 modern healthcare facilities, including 4 hospitals and 19 outpatient clinics in Moscow, St. Petersburg, Ufa, Perm, Samara and Samara region, Novosibirsk, Irkutsk, Yaroslavl and Ryazan. In addition, 3 franchised outpatient clinics operate in Kyiv, Ukraine.
In 2014, there were 4,550 deliveries; IVF cycles amounted to 7,654. Number of outpatient treatments totalled 818,636 and number of in-patient days reached 35,900.
The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.